Pub. Date : 2010 May 1
PMID : 20351323
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PURPOSE: Sunitinib and sorafenib are oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) used in a vast range of cancers. | Sunitinib | kinase insert domain receptor | Homo sapiens |
2 | PURPOSE: Sunitinib and sorafenib are oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) used in a vast range of cancers. | Sunitinib | kinase insert domain receptor | Homo sapiens |
3 | CONCLUSION: Treatment with VEGFR TKIs sunitinib and sorafenib is associated with a significant increase in the risk of ATEs. | Sunitinib | kinase insert domain receptor | Homo sapiens |